Short answer
Dynatrace Inc (DT) filed an 8-K current report with the SEC on August 20, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 3.02 (Unregistered Sales of Equity Securities). $1.4375B zero-coupon exchangeable notes due September 1, 2031, with no cash interest or principal accretion.
Dynatrace Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $1.4375B zero-coupon exchangeable notes due September 1, 2031, with no cash interest or principal accretion
- Net proceeds $1.411B, including $134.7M for repurchase of approximately 2.83M shares at $47.61
- Exchange price approximately $64.27, a 35.0% premium, limiting near-term exchange likelihood and dilution
- $167.8M spent on note hedges covering approximately 22.4M shares, generally offsetting exchange-related dilution and excess cash payments
- Warrants struck at $107.1225, a 125.0% premium, creating potential dilution only above that stock price threshold
Item 1.02 · Termination of a Material Definitive Agreement
- Termination of Dynatrace’s senior secured revolving credit facility linked to the Notes issuance
- Only outstanding obligations were letters of credit, fully cash collateralized from guarantor cash
- Revolver termination removes committed borrowing capacity but eliminates associated facility obligations and administrative requirements
Item 2.03 · Creation of a Direct Financial Obligation
- Financial obligation: Notes issued under an indenture, with terms referenced in Item 1.01
- Investor focus: Principal, interest rate, maturity and use of proceeds require review of Item 1.01 terms
Item 3.02 · Unregistered Sales of Equity Securities
- Notes and warrants issued through private-placement exemptions, limiting immediate public resale
- Notes initially exchangeable into up to 30,193,106 common shares at 21.0039 shares per $1,000 principal
- Warrants initially exercisable for up to 44,730,688 common shares
- Potential dilution of up to 74,923,794 shares, subject to anti-dilution adjustments
Item 8.01 · Other Events
- Dynatrace announced a proposed debt offering, signaling plans to raise financing
- Pricing was announced August 18, 2026, making transaction terms available in Exhibit 99.2
- Investors should assess offering size, interest rate and maturity for leverage and interest-cost impact
Item EX-99.1 · Exhibit EX-99.1
- Proposed $1.25B exchangeable senior notes due September 1, 2031, increasing leverage and future refinancing obligations
- Additional purchaser option for $187.5M, potentially raising total issuance to $1.4375B
- Up to approximately $200M earmarked for concurrent share repurchases, supporting per-share metrics but consuming financing proceeds
- Exchangeable notes hedge expected dilution, while warrants could dilute shares if Dynatrace’s stock exceeds warrant strike prices
- Interest rate and exchange terms remain unset until pricing, leaving final financing cost and dilution exposure unresolved
Item EX-99.2 · Exhibit EX-99.2
- $1.25B of 0.00% exchangeable notes due September 1, 2031, adding long-dated capital without regular cash interest
- Approximately $1.227B expected net proceeds, with remainder for general corporate purposes after hedging and repurchases
- $134.7M allocated to repurchase approximately 2.83M shares at $47.61, reducing share count and partially offsetting future exchange dilution
- Initial exchange price $64.27, a 35.0% premium, while warrants carry a higher $107.12 strike and potential dilution above that level
- $145.9M hedge cost designed to reduce exchange dilution, though warrant transactions could dilute shares if the stock exceeds $107.12
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Dynatrace Inc 8-K filings
Get the next DT 8-K as it lands
Follow DT for push alerts, or ask the research agent what this filing means.